Polaroid reorganizes business groups
Polaroid's restructuring plan took a step forward last week whenthe Cambridge, MA, developer of photography and imaging productsreorganized itself into three business units. Those units arethe consumer, commercial, and new business groups, with
Polaroid's restructuring plan took a step forward last week whenthe Cambridge, MA, developer of photography and imaging productsreorganized itself into three business units. Those units arethe consumer, commercial, and new business groups, with PolaroidMedical Imaging Systems falling under the new business umbrella.The reorganization is part of Polaroid's restructuring plan, whichwas announced last month (SCAN 12/27/95).
PMIS, of Newton, MA, previously operated in Polaroid's highresolution division, which has been retired under the new reorganizationplan. The head of the new business group is Robert Delahunt, formerlysenior vice president of photographic imaging.
There were no other changes to the structure of PMIS underthe new plan, according to spokesperson Robert Guenther. The subsidiary'ssenior management team, headed by Gerald Knudson, remains in place,he said.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
